Wireless monitoring company for cardiac patients recasts underwriting team for $182 million offering.
|
Wall Street unfazed by FDA panel’s rejection of company’s wireless heart monitoring device.
|
Medical device maker sees profit, shares dip.
|
The med-tech giant’s shares tick upward as defibrillator market stabilizes.
|
Boston Scientific’s CFO stands ground that buying troubled heart device maker Boston Scientific was the best thing the company ever did.
|
Year in Review: Innovation and controversy defined the medical technology industry.
|
The federal agency publishes plan that could improve post-market device safety.
|
Boston Sci may be closer to settling suits over defective pacemakers and defibrillators.
|
Despite slow defibrillator market, medical device maker reports results in line with lowered expectations.
|
Medical device maker squirrels away the money to deal with the legal woes of Guidant.
|
More companies weigh their IPO options in M&A slowdown.
|
Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
|
Healthcare giant grabs new brands to help extend its global reach.
|
J&J vows to appeal a judge’s decision that upholds rival company’s heart-device patent.
|
Conor Medsystems implants the first patient with a dual-drug heart device.
|
Medical device maker Guidant gets slapped with a lawsuit over its secrecy policy.
|
Recent recalls stir discussion on the reporting and replacement of faulty cardiac devices.
|
A lot of venture capitalists—maybe too many—have been snapping up opportunities in spinal devices.
|
Boston Scientific gets U.S. government clearance to acquire troubled heart device maker Guidant.
|
A U.S. agency’s plan to cut reimbursements for heart devices dents stocks of companies that make them.
|
Page
1
of
4
|